IL&FS INVESTMENT MANAGERS (IVC)

NSE: ₹8.18
BSE: ₹8.17
Stock Performance
Corporate Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the period ended March 31, 2026

2026-05-30 13:57:08
Board Meeting Outcome for Audited Consolidated Financial Statements/Financial Results For The Quarter And Financial Year Ended March 31, 2026

The Board of Directors of IL&FS Investment Managers Limited (“the Company”) at its meeting held today, i.e. May 30, 2026, inter alia, approved the Audited Consolidated Financial Statements/Financial Results for the quarter and financial year ended March 31, 2026 as recommended by the Audit Committee. Please find enclosed a copy of the said Financial Statements/ Results along with the Auditors’ Report with modified opinion on the aforesaid Audited Consolidated Financial Statements/ Results.

2026-05-30 12:48:58
Board Meeting Intimation for Intimation Of Board Meeting To Be Scheduled To Be Held On Saturday, May 30, 2026, Inter Alia, To Consider And Approve The Audited Consolidated Financial Statements/ Results Of The Company For The Quarter And Financial Year Ended March 31, 2026

Intimation of Board Meeting to be scheduled to be held on Saturday, May 30, 2026, inter alia, to consider and approve the Audited Consolidated Financial Statements/ Results of the Company for the quarter and financial year ended March 31, 2026

2026-05-29 19:25:35
Board Meeting Intimation for Intimation Of Board Meeting To Be Scheduled To Be Held On Saturday, May 30, 2026, Inter Alia, To Consider And Approve The Audited Consolidated Financial Statements/ Results Of The Company For The Quarter And Financial Year Ended March 31, 2026

Intimation of Board Meeting to be scheduled to be held on Saturday, May 30, 2026, inter alia, to consider and approve the Audited Consolidated Financial Statements/ Results of the Company for the quarter and financial year ended March 31, 2026

2026-05-29 19:24:01
Corporate Action-Board approves Dividend

Recommended a dividend of Rs. 0.70/- per equity share of face value Rs. 2/- each for the financial year ended March 31, 2026, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company

2026-05-29 19:07:34
Results - Standalone Financial Results For Mar 31, 2026

Approval of Audited Standalone Financial Statement/ Results for the quarter and year ended March 31, 2026

2026-05-29 18:56:13
Board Meeting Outcome for Outcome Of Board Meeting Dated 29-05-2026

1. Approved the Audited Standalone Financial Statements/ Results for the quarter and financial year ended March 31, 2026 2. Noted that the Audited Consolidated Financial Statements/Financial Results for the quarter and financial year ended March 31, 2026 could not be finalized and considered due to non-receipt of the Audited Financial Statements/Audit Report of one of the Subsidiaries, viz. IL&FS Investment Advisors LLC and its step down Subsidiary viz. Saffron Investment Trust. Accordingly, the Audit Committee and the Board of Directors shall consider and approve the Audited Consolidated Financial Statements/Financial Results at a separate meeting proposed to be convened on Saturday, May 30, 2026 3. Recommended a Dividend of ?0.70 per equity share of face value ?2 each for the financial year March 31, 2026, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company

2026-05-29 18:44:15
Board Meeting Outcome for Outcome Of Board Meeting Dated 29-05-2026

1. Approved the Audited Standalone Financial Statements/ Results for the quarter and financial year ended March 31, 2026 2. Noted that the Audited Consolidated Financial Statements/Financial Results for the quarter and financial year ended March 31, 2026 could not be finalized and considered due to non-receipt of the Audited Financial Statements/Audit Report of one of the Subsidiaries, viz. IL&FS Investment Advisors LLC and its step down Subsidiary viz. Saffron Investment Trust. Accordingly, the Audit Committee and the Board of Directors shall consider and approve the Audited Consolidated Financial Statements/Financial Results at a separate meeting proposed to be convened on Saturday, May 30, 2026 3. Recommended a Dividend of ?0.70 per equity share of face value ?2 each for the financial year March 31, 2026, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company

2026-05-29 18:40:50
Announcement under Regulation 30 (LODR)-Newspaper Publication

We are enclosing herewith copies of newspaper clippings published on 20-05-2026 in Financial Express (English- All editions) and Mumbai Lakshadeep (Marathi) regarding the opening of the Special Window for the Transfer and dematerialisation of physical shares vide SEBI Circular HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30-01-2026

2026-05-22 15:41:13
Board Meeting Intimation for Adoption Of Financial Statements/ Results For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of Final Dividend On The Equity Shares Of The Company For The Financial Year 2025-2026, If Any

1. The Audited Standalone and Consolidated Financial Statements/ Results of the Company for the quarter and financial year ended March 31, 2026; 2. Recommendation of Final dividend on the Equity Shares of the Company for the Financial Year 2025-2026, if any;

2026-05-22 14:40:37

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 17.51 13.30 11.63 13.81 13.18 7.77 5.20 8.52 7.58 5.80 7.17 6.73
YOY Revenue Growth % 49.27% -21.89% -26.37% -2.12% -24.73% -41.53% -55.27% -38.31% -42.52% -25.42% 37.71% -20.99%
Other Income 3.39 4.91 3.21 2.95 3.42 2.19 3.45 5.22 7.45 3.09 3.87 1.84
Total Income 20.90 18.21 14.85 16.77 16.60 9.96 8.65 13.74 15.03 8.89 11.03 8.57
Total Expenses + 16.98 12.83 13.08 14.47 10.44 11.93 5.40 9.14 6.39 8.46 6.12 11.41
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 3.69 3.67 3.00 3.51 2.75 3.17 2.86 2.56 2.36 2.01 2.19 2.47
Other Expenses 13.23 9.11 10.03 10.88 7.61 8.69 2.48 6.53 3.98 6.39 3.89 8.90
Operating Profit 0.53 0.47 -1.45 -0.65 2.74 -4.16 -0.20 -0.62 1.19 -2.66 1.05 -4.67
OPM % 3% 3.5% -12.4% -4.7% 20.8% -53.5% -3.8% -7.3% 15.7% -45.9% 14.6% -69.4%
Profit Before Tax + 3.93 5.38 1.76 2.30 6.16 -1.97 3.25 4.60 8.64 0.43 4.91 -2.84
Tax Expense 0.30 2.30 0.02 0.02 1.22 1.75 1.67 0.89 -4.03 0.21 1.38 0.09
Tax % 7.7% 42.8% 1% 0.9% 19.7% - 51.2% 19.4% -46.7% 47.5% 28% -
Profit After Tax 3.62 3.08 1.75 2.28 4.94 -3.72 1.59 3.71 12.68 0.23 3.53 -2.93
EPS (Basic) 0.08 0.05 0.07 0.04 0.15 -0.11 0.03 0.10 0.39 0.03 0.09 -0.06

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 29.08 51.92 64.45 41.65 46.14 36.43
YOY Revenue Growth % -44% -19.43% 54.72% -9.72% 26.64% -
Other Income 17.56 14.49 11.07 15.77 12.48 12.23
Total Income 46.64 66.42 75.51 57.42 58.62 48.67
Total Expenses + 32.12 50.82 57.09 42.11 48.73 55.23
Employee Benefit Expense 10.95 12.93 15.32 16.88 17.29 22.84
Other Expenses 20.92 37.63 41.58 25.02 26.08 31.77
Operating Profit -3.04 1.11 7.36 -0.46 -2.59 -18.79
OPM % -10.5% 2.1% 11.4% -1.1% -5.6% -51.6%
Profit Before Exceptional 14.52 15.60 18.42 15.31 9.89 -6.56
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 14.52 15.60 18.42 15.31 9.89 -6.56
Tax Expense 0.28 3.55 1.43 2.20 0.32 13.13
Tax % 1.9% 22.8% 7.7% 14.3% 3.2% -
Profit After Tax 14.24 12.05 17.00 13.12 9.58 -19.68
EPS (Basic) 0.42 0.32 0.38 0.25 0.50 -0.44

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 0.00 0.00 0.00 0.00 0.00 0.00
Property, Plant & Equipment 0.39 0.46 0.39 0.28 0.41 0.45
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.01 0.02 0.00 0.00 0.01 0.08
Current Assets + 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00
Trade Receivables 0.00 0.00 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 9.02 19.25 23.52 69.33 84.49 100.83
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 222.18 236.88 229.66 223.32 234.25
Equity Share Capital 62.81 62.81 62.81 62.81 62.81 62.81
Other Equity 142.31 139.58 153.61 147.92 146.90 159.59
Non-Current Liabilities 0.00 0.00 0.00 0.00 0.00 0.00
Current Liabilities 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities 13.32 27.20 30.12 25.20 26.46 28.40

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities -8.90 -6.10 -0.48 6.43 10.74 0.00
Cash from Investing Activities 19.45 28.35 -36.17 -15.16 -5.76 0.00
Cash from Financing Activities -21.98 -27.72 -16.09 -9.42 -18.84 0.00
Net Increase/Decrease in Cash -10.23 -4.27 -45.81 -15.16 -16.34 0.00